Logo-bi
Bioimpacts. 2017;7(2): 99-108. doi: 10.15171/bi.2017.13
PMID: 28752074        PMCID: PMC5524991

Original Research

Co-liquefaction with acetone and GC analysis of volatile compounds in exhaled breath as lung cancer biomarkers

Abolghasem Jouyban 1,2 * , Djavanshir Djozan 3, Parastou Mohammadandashti 3, Aliakbar Alizadeh-Nabil 4, Hooshangh Ghorbanpour 4, Maryam Khoubnasabjafari 5, Mohammad Mohammadzadeh 6

Cited by CrossRef: 12

1- Gashimova E, Osipova A, Temerdashev A, Porkhanov V, Polyakov I, Perunov D, Dmitrieva E. Exhaled breath analysis using GC-MS and an electronic nose for lung cancer diagnostics. Anal Methods. 2021;13(40):4793 [Crossref]
2- Sutaria S, Gori S, Morris J, Xie Z, Fu X, Nantz M. Lipid Peroxidation Produces a Diverse Mixture of Saturated and Unsaturated Aldehydes in Exhaled Breath That Can Serve as Biomarkers of Lung Cancer—A Review. Metabolites. 2022;12(6):561 [Crossref]
3- Ghosh C, Singh V, Grandy J, Pawliszyn J. Recent advances in breath analysis to track human health by new enrichment technologies. J of Separation Science. 2020;43(1):226 [Crossref]
4- Zou Y, Wang Y, Jiang Z, Zhou Y, Chen Y, Hu Y, Jiang G, Xie D. Breath profile as composite biomarkers for lung cancer diagnosis. Lung Cancer. 2021;154:206 [Crossref]
5- Vassilenko V, Moura P, Raposo M. Diagnosis of Carcinogenic Pathologies through Breath Biomarkers: Present and Future Trends. Biomedicines. 2023;11(11):3029 [Crossref]
6- Gashimova E, Temerdashev A, Porkhanov V, Polyakov I, Perunov D. Volatile Organic Compounds in Exhaled Breath as Biomarkers of Lung Cancer: Advances and Potential Problems. J Anal Chem. 2022;77(7):785 [Crossref]
7- Saleh P, Hosseini M, Piri R, Ghaffari M, Mohammadi S, Naghavi-Behzad M. Association of Lung Cancer and Tuberculosis: A Cross Sectional Study from Northwest of Iran. Int J Cancer Manag. 2019;12(6) [Crossref]
8- Roopa Kishore K, Balamurugan D, Jeyaprakash B. CuO nanograins: synthesis and acetone vapour detection. J Mater Sci: Mater Electron. 2021;32(1):1204 [Crossref]
9- Lundberg R, Dahlén J, Lundeberg T. Considerations regarding the selection, sampling, extraction, analysis, and modelling of biomarkers in exhaled breath for early lung cancer screening. Journal of Pharmaceutical and Biomedical Analysis. 2025;260:116787 [Crossref]
10- Pereira F, Domingues M, Vitorino R, Guerra I, Santos L, Ferreira J, Ferreira R. Unmasking the Metabolite Signature of Bladder Cancer: A Systematic Review. IJMS. 2024;25(6):3347 [Crossref]
11- Díaz de León-Martínez L, Flores-Ramírez R, López-Mendoza C, Rodríguez-Aguilar M, Metha G, Zúñiga-Martínez L, Ornelas-Rebolledo O, Alcántara-Quintana L. Identification of volatile organic compounds in the urine of patients with cervical cancer. Test concept for timely screening. Clinica Chimica Acta. 2021;522:132 [Crossref]
12- Raha S, Fathi A, Afshar Mogaddam M, Shahedi-Hodjaghan A, Farajzadeh M, Hosseini M, Khoubnasabjafari M, Jouyban-Gharamaleki V, Jouyban A. Heteroatom cobalt-based metal-organic framework and reduced graphene oxide nanocomposite for dispersive solid phase extraction of caffeine from exhaled breath condensate samples of premature infants prior to HPLC-PDA. Journal of Chromatography B. 2024;1248:124339 [Crossref]

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate (2024): 20% 
Publication fee: Free of charge

Indexing/Abstracting Info
PubMed; PubMed Central; Scopus; Science Citation Index Expanded; Google Scholar;   SJR; Essential Science Indicators; Embase; EBSCOhost; CAS: DOAJ: SHERPA/RoMEO
Member of COPE
Follower of ICMJE
Permission: Creative Commons